ENHANCEMENTS IN RECOMBINANT HUMAN SERUM ALBUMIN FOR BIOPHARMACEUTICAL APPS

Recombinant human serum albumin (OsrHSA) has emerged as a major innovation in the sphere of biopharmaceuticals, providing promising developments across a variety of clinical and industrial applications. With its structural similarity to By natural means derived human serum albumin, OsrHSA gives a safer, far more reputable alternate for therapeutic